{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:46:10Z","timestamp":1791384370350,"version":"4.3.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Several novel urinary kidney damage biomarkers predict the progression of kidney disease. However, the relations of these biomarkers to atherosclerosis, a major consequence of kidney disease, are less studied. Urinary levels of several biomarkers, including kidney injury molecule-1 (KIM-1), osteopontin, epidermal growth factor, and Dickkopf-3, were assessed in participants enrolled in the Swedish CArdioPulmonary BioImage Study. The study included 9,628 individuals with a mean age of 57.5 years, of which 52.4% were women. The presence of coronary artery stenosis and the coronary artery calcium score (CACS) were determined using coronary computed tomography angiography. To analyze the associations between coronary atherosclerosis and urinary biomarker levels, an ordered logistic regression model adusting for confounding factors was employed. KIM-1 was the only biomarker associated with both coronary stenosis and CACS after adjusting for established cardiovascular risk factors (odds ratio [95% confidence intervals], 1.23[1.05\u20131.44] and 1.25[1.07\u20131.47]). These results were consistent in sensitivity analyses of individuals without hypertension, diabetes, or known cardiovascular disease and with normal kidney function. Urinary KIM-1, a specific marker of proximal tubular damage, was robustly linked to coronary atherosclerosis even in apparently healthy individuals, which suggests that the detrimental interplay between the kidney and cardiovascular system begins before clinically overt kidney disease. Additional studies are warranted to evaluate the urinary KIM-1 to predict kidney and cardiovascular disease.<\/jats:p>","DOI":"10.1038\/s41598-024-80321-5","type":"journal-article","created":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T14:06:12Z","timestamp":1732543572000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The association between novel urinary kidney damage biomarkers and coronary atherosclerosis in an apparently healthy population"],"prefix":"10.1038","volume":"14","author":[{"given":"Yi-Ting","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Wuopio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Malinovschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Feldreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Engstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tove","family":"Fall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"\u00c4rnl\u00f6v","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,25]]},"reference":[{"key":"80321_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"GBDCKD Collaboration","year":"2020","unstructured":"GBDCKD Collaboration. Global, regional, and national burden of chronic kidney disease, 1990\u20132017: A systematic analysis for the global burden of disease study 2017. Lancet 395, 709\u2013733. https:\/\/doi.org\/10.1016\/S0140-6736(20)30045-3 (2020).","journal-title":"Lancet"},{"key":"80321_CR2","doi-asserted-by":"publisher","unstructured":"Webster, A. C., Nagler, E. V., Morton, R. L. & Masson, P. Chronic kidney disease. Lancet 389, 1238\u20131252. https:\/\/doi.org\/10.1016\/S0140-6736(16)32064-5 (2017).","DOI":"10.1016\/S0140-6736(16)32064-5"},{"key":"80321_CR3","doi-asserted-by":"publisher","first-page":"e2225821","DOI":"10.1001\/jamanetworkopen.2022.25821","volume":"5","author":"M Pasternak","year":"2022","unstructured":"Pasternak, M. et al. Association of albuminuria and regression of chronic kidney disease in adults with newly diagnosed moderate to severe chronic kidney disease. JAMA Netw. Open. 5, e2225821. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.25821 (2022).","journal-title":"JAMA Netw. Open."},{"key":"80321_CR4","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/ki.1972.30","volume":"1","author":"FS Wright","year":"1972","unstructured":"Wright, F. S. & Giebisch, G. Glomerular filtration in single nephrons. Kidney Int. 1, 201\u2013209. https:\/\/doi.org\/10.1038\/ki.1972.30 (1972).","journal-title":"Kidney Int."},{"key":"80321_CR5","doi-asserted-by":"publisher","first-page":"100662","DOI":"10.1016\/j.eclinm.2020.100662","volume":"29-30","author":"BJ Nankivell","year":"2020","unstructured":"Nankivell, B. J., Nankivell, L. F. J., Elder, G. J. & Gruenewald, S. M. How unmeasured muscle mass affects estimated GFR and diagnostic inaccuracy. EClinicalMedicine 29-30, 100662. https:\/\/doi.org\/10.1016\/j.eclinm.2020.100662 (2020).","journal-title":"EClinicalMedicine"},{"key":"80321_CR6","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1053\/j.ajkd.2018.04.023","volume":"72","author":"SS Waikar","year":"2018","unstructured":"Waikar, S. S. et al. Biological variability of estimated GFR and albuminuria in CKD. Am. J. Kidney Dis. 72, 538\u2013546. https:\/\/doi.org\/10.1053\/j.ajkd.2018.04.023 (2018).","journal-title":"Am. J. Kidney Dis."},{"key":"80321_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev-physiol-020518-114605","volume":"81","author":"WR Zhang","year":"2019","unstructured":"Zhang, W. R. & Parikh, C. R. Biomarkers of acute and chronic kidney disease. Annu. Rev. Physiol. 81, 309\u2013333. https:\/\/doi.org\/10.1146\/annurev-physiol-020518-114605 (2019).","journal-title":"Annu. Rev. Physiol."},{"key":"80321_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1046\/j.1523-1755.2002.00433.x","volume":"62","author":"WK Han","year":"2002","unstructured":"Han, W. K., Bailly, V., Abichandani, R., Thadhani, R. & Bonventre, J. V. Kidney injury molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury. Kidney Int. 62, 237\u2013244. https:\/\/doi.org\/10.1046\/j.1523-1755.2002.00433.x (2002).","journal-title":"Kidney Int."},{"key":"80321_CR9","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1172\/JCI117501","volume":"94","author":"LA Fitzpatrick","year":"1994","unstructured":"Fitzpatrick, L. A., Severson, A., Edwards, W. D. & Ingram, R. T. Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis. J. Clin. Invest. 94, 1597\u20131604. https:\/\/doi.org\/10.1172\/JCI117501 (1994).","journal-title":"J. Clin. Invest."},{"key":"80321_CR10","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1159\/000319490","volume":"32","author":"C Zhou","year":"2010","unstructured":"Zhou, C. et al. Blockade of osteopontin inhibits glomerular fibrosis in a model of anti-glomerular basement membrane glomerulonephritis. Am. J. Nephrol. 32, 324\u2013331. https:\/\/doi.org\/10.1159\/000319490 (2010).","journal-title":"Am. J. Nephrol."},{"key":"80321_CR11","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.kint.2019.01.035","volume":"96","author":"K Azukaitis","year":"2019","unstructured":"Azukaitis, K. et al. Low levels of urinary epidermal growth factor predict chronic kidney disease progression in children. Kidney Int. 96, 214\u2013221. https:\/\/doi.org\/10.1016\/j.kint.2019.01.035 (2019).","journal-title":"Kidney Int."},{"key":"80321_CR12","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/ndt\/gfaa003","volume":"36","author":"SJ Schunk","year":"2021","unstructured":"Schunk, S. J., Speer, T., Petrakis, I. & Fliser, D. Dickkopf 3-a novel biomarker of the \u2018kidney injury continuum\u2019. Nephrol. Dial Transplant. 36, 761\u2013767. https:\/\/doi.org\/10.1093\/ndt\/gfaa003 (2021).","journal-title":"Nephrol. Dial Transplant."},{"key":"80321_CR13","doi-asserted-by":"publisher","unstructured":"Patel, M. R. et al. Prevalence and predictors of nonobstructive coronary artery disease identified with coronary angiography in contemporary clinical practice. Am Heart J 167, 846\u2013852 e842 https:\/\/doi.org\/10.1016\/j.ahj.2014.03.001 (2014).","DOI":"10.1016\/j.ahj.2014.03.001"},{"key":"80321_CR14","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jacc.2018.05.027","volume":"72","author":"P Greenland","year":"2018","unstructured":"Greenland, P., Blaha, M. J., Budoff, M. J., Erbel, R. & Watson, K. E. Coronary calcium score and cardiovascular risk. J. Am. Coll. Cardiol. 72, 434\u2013447. https:\/\/doi.org\/10.1016\/j.jacc.2018.05.027 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"80321_CR15","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1161\/CIRCULATIONAHA.121.055340","volume":"144","author":"G Bergstrom","year":"2021","unstructured":"Bergstrom, G. et al. Prevalence of subclinical coronary artery atherosclerosis in the general population. Circulation 144, 916\u2013929. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.055340 (2021).","journal-title":"Circulation"},{"key":"80321_CR16","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-t","volume":"15","author":"AS Agatston","year":"1990","unstructured":"Agatston, A. S. et al. Quantification of coronary artery calcium using ultrafast computed tomography. J. Am. Coll. Cardiol. 15, 827\u2013832. https:\/\/doi.org\/10.1016\/0735-1097(90)90282-t (1990).","journal-title":"J. Am. Coll. Cardiol."},{"key":"80321_CR17","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker, L. A. et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl. J. Med. 385, 1737\u20131749. https:\/\/doi.org\/10.1056\/NEJMoa2102953 (2021).","journal-title":"N Engl. J. Med."},{"key":"80321_CR18","doi-asserted-by":"publisher","first-page":"E60","DOI":"10.1210\/jc.2012-3038","volume":"98","author":"TC Register","year":"2013","unstructured":"Register, T. C. et al. Plasma Dickkopf1 (DKK1) concentrations negatively associate with atherosclerotic calcified plaque in African-Americans with type 2 diabetes. J. Clin. Endocrinol. Metab. 98, E60\u201365. https:\/\/doi.org\/10.1210\/jc.2012-3038 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"80321_CR19","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.atherosclerosis.2013.06.003","volume":"229","author":"AE Berezin","year":"2013","unstructured":"Berezin, A. E. & Kremzer, A. A. Circulating osteopontin as a marker of early coronary vascular calcification in type two diabetes mellitus patients with known asymptomatic coronary artery disease. Atherosclerosis 229, 475\u2013481. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.06.003 (2013).","journal-title":"Atherosclerosis"},{"key":"80321_CR20","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1159\/000476001","volume":"7","author":"T Feldreich","year":"2017","unstructured":"Feldreich, T. et al. Urinary osteopontin predicts incident chronic kidney disease, while plasma osteopontin predicts cardiovascular death in elderly men. Cardiorenal Med. 7, 245\u2013254. https:\/\/doi.org\/10.1159\/000476001 (2017).","journal-title":"Cardiorenal Med."},{"key":"80321_CR21","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12872-016-0314-3","volume":"16","author":"M Sponder","year":"2016","unstructured":"Sponder, M. et al. Osteopontin is elevated in patients with mitral annulus calcification independent from classic cardiovascular risk factors. BMC Cardiovasc. Disord. 16, 132. https:\/\/doi.org\/10.1186\/s12872-016-0314-3 (2016).","journal-title":"BMC Cardiovasc. Disord"},{"key":"80321_CR22","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.kint.2015.12.046","volume":"89","author":"NJ Paloian","year":"2016","unstructured":"Paloian, N. J., Leaf, E. M. & Giachelli, C. M. Osteopontin protects against high phosphate-induced nephrocalcinosis and vascular calcification. Kidney Int. 89, 1027\u20131036. https:\/\/doi.org\/10.1016\/j.kint.2015.12.046 (2016).","journal-title":"Kidney Int."},{"key":"80321_CR23","doi-asserted-by":"publisher","first-page":"761","DOI":"10.2215\/CJN.08560816","volume":"12","author":"M Park","year":"2017","unstructured":"Park, M. et al. Urine kidney injury biomarkers and risks of cardiovascular disease events and all-cause death: The CRIC study. Clin. J. Am. Soc. Nephrol. 12, 761\u2013771. https:\/\/doi.org\/10.2215\/CJN.08560816 (2017).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"80321_CR24","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.2215\/CJN.11901113","volume":"9","author":"AC Carlsson","year":"2014","unstructured":"Carlsson, A. C. et al. Urinary kidney injury molecule-1 and the risk of cardiovascular mortality in elderly men. Clin. J. Am. Soc. Nephrol. 9, 1393\u20131401. https:\/\/doi.org\/10.2215\/CJN.11901113 (2014).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"80321_CR25","doi-asserted-by":"publisher","first-page":"358","DOI":"10.5414\/CN108668","volume":"84","author":"M Park","year":"2015","unstructured":"Park, M. et al. Associations of kidney injury markers with subclinical cardiovascular disease: The multi-ethnic study of atherosclerosis. Clin. Nephrol. 84, 358\u2013363. https:\/\/doi.org\/10.5414\/CN108668 (2015).","journal-title":"Clin. Nephrol."},{"key":"80321_CR26","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/MCC.0b013e32834008d3","volume":"16","author":"JV Bonventre","year":"2010","unstructured":"Bonventre, J. V. & Yang, L. Kidney injury molecule-1. Curr. Opin. Crit. Care. 16, 556\u2013561. https:\/\/doi.org\/10.1097\/MCC.0b013e32834008d3 (2010).","journal-title":"Curr. Opin. Crit. Care"},{"key":"80321_CR27","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1093\/ndt\/gfp010","volume":"24","author":"JV Bonventre","year":"2009","unstructured":"Bonventre, J. V. Kidney injury molecule-1 (KIM-1): A urinary biomarker and much more. Nephrol. Dial Transpl. 24, 3265\u20133268. https:\/\/doi.org\/10.1093\/ndt\/gfp010 (2009).","journal-title":"Nephrol. Dial Transpl."},{"key":"80321_CR28","doi-asserted-by":"publisher","first-page":"F1472","DOI":"10.1152\/ajprenal.00619.2009","volume":"298","author":"GJ Ko","year":"2010","unstructured":"Ko, G. J. et al. Transcriptional analysis of kidneys during repair from AKI reveals possible roles for NGAL and KIM-1 as biomarkers of AKI-to-CKD transition. Am. J. Physiol. Ren. Physiol. 298, F1472\u20131483. https:\/\/doi.org\/10.1152\/ajprenal.00619.2009 (2010).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"80321_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11010-016-2700-7","volume":"416","author":"Z Zhang","year":"2016","unstructured":"Zhang, Z. & Cai, C. X. Kidney injury molecule-1 (KIM-1) mediates renal epithelial cell repair via ERK MAPK signaling pathway. Mol. Cell. Biochem. 416, 109\u2013116. https:\/\/doi.org\/10.1007\/s11010-016-2700-7 (2016).","journal-title":"Mol. Cell. Biochem."},{"key":"80321_CR30","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1172\/JCI45361","volume":"123","author":"BD Humphreys","year":"2013","unstructured":"Humphreys, B. D. et al. Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis. J. Clin. Invest. 123, 4023\u20134035. https:\/\/doi.org\/10.1172\/JCI45361 (2013).","journal-title":"J. Clin. Invest."},{"key":"80321_CR31","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/eji.201040993","volume":"41","author":"S Xiao","year":"2011","unstructured":"Xiao, S. et al. Tim-1 stimulation of dendritic cells regulates the balance between effector and regulatory T cells. Eur. J. Immunol. 41, 1539\u20131549. https:\/\/doi.org\/10.1002\/eji.201040993 (2011).","journal-title":"Eur. J. Immunol."},{"issue":"e416","key":"80321_CR32","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jaci.2013.03.025","volume":"132","author":"HY Kim","year":"2013","unstructured":"Kim, H. Y. et al. T-cell immunoglobulin and mucin domain 1 deficiency eliminates airway hyperreactivity triggered by the recognition of airway cell death. J. Allergy Clin. Immunol. 132 (e416), 414\u2013425. https:\/\/doi.org\/10.1016\/j.jaci.2013.03.025 (2013).","journal-title":"J. Allergy Clin. Immunol."},{"key":"80321_CR33","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1365-3083.2007.02038.x","volume":"67","author":"Y Wang","year":"2008","unstructured":"Wang, Y. et al. Expression of human TIM-1 and TIM-3 on lymphocytes from systemic lupus erythematosus patients. Scand. J. Immunol. 67, 63\u201370. https:\/\/doi.org\/10.1111\/j.1365-3083.2007.02038.x (2008).","journal-title":"Scand. J. Immunol."},{"key":"80321_CR34","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1182\/blood-2006-11-058800","volume":"110","author":"S Nakae","year":"2007","unstructured":"Nakae, S. et al. TIM-1 and TIM-3 enhancement of Th2 cytokine production by mast cells. Blood 110, 2565\u20132568. https:\/\/doi.org\/10.1182\/blood-2006-11-058800 (2007).","journal-title":"Blood"},{"key":"80321_CR35","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.lfs.2007.12.017","volume":"82","author":"G Xu","year":"2008","unstructured":"Xu, G. et al. Expression of T-cell immunoglobulin- and mucin-domain-containing molecule-1 (TIM-1) is increased in a mouse model of asthma and relationship to GATA-3. Life Sci. 82, 663\u2013669. https:\/\/doi.org\/10.1016\/j.lfs.2007.12.017 (2008).","journal-title":"Life Sci."},{"key":"80321_CR36","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.imlet.2006.11.004","volume":"108","author":"RM Hein","year":"2007","unstructured":"Hein, R. M. & Woods, M. L. TIM-1 regulates macrophage cytokine production and B7 family member expression. Immunol. Lett. 108, 103\u2013108. https:\/\/doi.org\/10.1016\/j.imlet.2006.11.004 (2007).","journal-title":"Immunol. Lett."},{"key":"80321_CR37","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/eurjhf\/hfs187","volume":"15","author":"AC Carlsson","year":"2013","unstructured":"Carlsson, A. C. et al. Urinary kidney injury molecule 1 and incidence of heart failure in elderly men. Eur. J. Heart Fail. 15, 441\u2013446. https:\/\/doi.org\/10.1093\/eurjhf\/hfs187 (2013).","journal-title":"Eur. J. Heart Fail."},{"key":"80321_CR38","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/sj.ki.5002273","volume":"72","author":"PE Stevens","year":"2007","unstructured":"Stevens, P. E. et al. Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int. 72, 92\u201399. https:\/\/doi.org\/10.1038\/sj.ki.5002273 (2007).","journal-title":"Kidney Int."},{"key":"80321_CR39","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1161\/ATVBAHA.119.312705","volume":"39","author":"JM Valdivielso","year":"2019","unstructured":"Valdivielso, J. M. et al. Atherosclerosis in chronic kidney disease: More, less, or just different? Arterioscler. Thromb. Vasc Biol. 39, 1938\u20131966. https:\/\/doi.org\/10.1161\/ATVBAHA.119.312705 (2019).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"80321_CR40","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.7326\/0003-4819-103-6-1010","volume":"103","author":"EL Barrett-Connor","year":"1985","unstructured":"Barrett-Connor, E. L. Obesity, atherosclerosis, and coronary artery disease. Ann. Intern. Med. 103, 1010\u20131019. https:\/\/doi.org\/10.7326\/0003-4819-103-6-1010 (1985).","journal-title":"Ann. Intern. Med."},{"key":"80321_CR41","doi-asserted-by":"publisher","first-page":"e9349","DOI":"10.7759\/cureus.9349","volume":"12","author":"MA Khan","year":"2020","unstructured":"Khan, M. A. et al. Global epidemiology of ischemic heart disease: Results from the global burden of disease study. Cureus 12, e9349. https:\/\/doi.org\/10.7759\/cureus.9349 (2020).","journal-title":"Cureus"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80321-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80321-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80321-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T15:04:36Z","timestamp":1732547076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80321-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,25]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["80321"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-80321-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,25]]},"assertion":[{"value":"27 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"J.\u00c4. has received lecture fees from Novartis and AstraZeneca, and served on advisory boards for Astella, AstraZeneca and Boehringer Ingelheim, all unrelated to the present paper. All other authors report no conflicts of interest in connection with this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29215"}}